BCAX financials
Bicara Therapeutics (BCAX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
BCAX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | – | – | -$155.60M | -$137.95M | -2.52 |
| 2024 | – | – | -$82.39M | -$68.00M | -4.05 |
| 2023 | – | – | -$39.89M | -$51.98M | -89.61 |